Comment: In Response to �CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML�

Comment: In Response to �CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML� [Turk J Hematol]

Turk J Hematol. 2020; 37(4): 289-290 | DOI: 10.4274/tjh.galenos.2020.2020.0572

Comment: In Response to �CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML�

Smeeta Gajendra
Laboratory Oncology Unit, Dr. B.R.A. IRCH, AIIMS, New Delhi, India

Keywords: Acute promyelocytic leukemia, Flow cytometry, CD9, CD18

Yorum: �CD9 AML-M3�� HLA-DR Negatif M3 D�� AML�den Ay�rt Etmede �ok Faydal� Bir Belirte�tir

Smeeta Gajendra
Laboratory Oncology Unit, Dr. B.R.A. IRCH, AIIMS, New Delhi, India

Anahtar Kelimeler: Akut promiyelositik l�semi, Ak�� sitometrisi, CD9, CD18

Smeeta Gajendra. Comment: In Response to �CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML�. Turk J Hematol. 2020; 37(4): 289-290

Corresponding Author: Smeeta Gajendra, India

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact

Comment: In Response to �CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML�

Yorum: �CD9 AML-M3�� HLA-DR Negatif M3 D��� AML�den Ay�rt Etmede �ok Faydal� Bir Belirte�tir

Yorum: �CD9 AML-M3�� HLA-DR Negatif M3 D�� AML�den Ay�rt Etmede �ok Faydal� Bir Belirte�tir